BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19759028)

  • 1. Diffuse involvement of the heart and great vessels in primary cardiac lymphoma.
    Kaderli AA; Baran I; Aydin O; Bicer M; Akpinar T; Ozkalemkas F; Yesilbursa D; Gullulu S
    Eur J Echocardiogr; 2010 Jan; 11(1):74-6. PubMed ID: 19759028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).
    Mamot C; Klingbiel D; Hitz F; Renner C; Pabst T; Driessen C; Mey U; Pless M; Bargetzi M; Krasniqi F; Gigli F; Hany T; Samarin A; Biaggi C; Rusterholz C; Dirnhofer S; Zucca E; Martinelli G
    J Clin Oncol; 2015 Aug; 33(23):2523-9. PubMed ID: 26150440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic findings of intracardiac mass.
    Tanaka H; Kawai H; Ishida T; Yoshida A; Yokoyama M
    J Cardiol; 2007 Aug; 50(2):155-7. PubMed ID: 17802700
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis of a primary cardiac B-cell lymphoma.
    Menke J; Unterberg-Buchwald C; Schaefer IM; Kertesz A
    Am J Hematol; 2012 Apr; 87(4):426-7. PubMed ID: 21953722
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
    Nonami A; Takenaka K; Kamezaki K; Miyamoto T; Harada N; Nagafuji K; Teshima T; Harada M
    Int J Hematol; 2007 Apr; 85(3):264-6. PubMed ID: 17483065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma.
    Wu X; Pertovaara H; Korkola P; Vornanen M; Järvenpää R; Dastidar P; Eskola H; Kellokumpu-Lehtinen PL
    Acta Oncol; 2014 Aug; 53(8):1093-9. PubMed ID: 24960581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
    Martelli M; Ceriani L; Zucca E; Zinzani PL; Ferreri AJ; Vitolo U; Stelitano C; Brusamolino E; Cabras MG; Rigacci L; Balzarotti M; Salvi F; Montoto S; Lopez-Guillermo A; Finolezzi E; Pileri SA; Davies A; Cavalli F; Giovanella L; Johnson PW
    J Clin Oncol; 2014 Jun; 32(17):1769-75. PubMed ID: 24799481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the PET-CT in the evaluation of early response to treatment in the diffuse large B-cell lymphoma. Preliminary results.
    Cortés Romera M; Gámez Cenzano C; Caresia Aróztegui AP; Martín-Comín J; González-Barca E; Ricart Brulles Y; Palacios Abufón A; Robles Barba J; Rodríguez-Bel L; Rossi Seoane S; Fernández de Sevilla A
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):135-41. PubMed ID: 21944191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resistance to first line chemotherapy treatment in a patient diagnosed of nodular lymphocyte-predominant Hodgkin's lymphoma identified by 18F-FDG PET/CT: diagnostic and therapeutic implications].
    Banzo J; Ubieto MA; Giraldo P; Razola P; Prats E; Tardin L; Santapau A; Parra A; Rambalde EF; Velilla J
    Rev Esp Med Nucl Imagen Mol; 2012; 31(2):89-92. PubMed ID: 21620527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
    Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
    Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.
    Takeoka Y; Inaba A; Fujitani Y; Kosaka S; Yamamura R; Senzaki H; Okamura T; Ohta K
    Rinsho Ketsueki; 2011 Nov; 52(11):1777-81. PubMed ID: 22185801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of interim FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: Systematic review and meta-analysis.
    Adams HJ; Kwee TC
    Crit Rev Oncol Hematol; 2016 Oct; 106():55-63. PubMed ID: 27637352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report].
    Hashimoto A; Fujimi A; Kanisawa Y; Matsuno T; Okuda T; Minami S; Doi T; Ishikawa K; Uemura N; Jyomen Y; Tomaru U
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2589-92. PubMed ID: 24335377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The successful treatment of primary cardiac lymphoma with a dose-dense schedule of rituximab plus CHOP.
    Dawson MA; Mariani J; Taylor A; Koulouris G; Avery S
    Ann Oncol; 2006 Jan; 17(1):176-7. PubMed ID: 16157624
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy.
    Cox MC; Ambrogi V; Lanni V; Cavalieri E; Pelliccia S; Scopinaro F; Monarca B; Marchetti P; Spiriti MA
    Leuk Lymphoma; 2012 Feb; 53(2):263-9. PubMed ID: 21846184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated Lymphoma Evolving into Neurolymphomatosis during Mid-cycle of Chemotherapy Detected by (18)F-FDG PET/CT.
    Tong AK; Neo SH; Kok TY
    Ann Acad Med Singap; 2015 Nov; 44(11):545-7. PubMed ID: 27089963
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary bone lymphoma involving bilateral tibia.
    Giardino AA; Shinagare AB; Shinagare SA; Dewar R; Weckstein D; Mauch P; Ramaiya NH; Freedman AS
    Am J Hematol; 2012 Sep; 87(9):924-5. PubMed ID: 22641233
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary cardiac lymphoma: utility of multimodality imaging in diagnosis and management.
    Mato AR; Morgans AK; Roullet MR; Bagg A; Glatstein E; Litt HI; Downs LH; Chong EA; Olson ER; Andreadis C; Schuster SJ
    Cancer Biol Ther; 2007 Dec; 6(12):1867-70. PubMed ID: 18075298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful combined treatment of primary cardiac malignant lymphoma with urgent cardiac operation and chemotherapy.
    Fujita Y; Ikebuchi M; Tarui S; Irie H
    Circ J; 2009 May; 73(5):967-9. PubMed ID: 19088397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.